Skip to main content

Table 1 Patient demographics and mutations

From: The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy

Characteristics All patients (N = 25)
Age (years) 8.2 (2.2)
Height (cm) 120.1 (10.4)
Weight (kg) 28.2 (9.1)
BMI (kg/m2) 19.1 (3.7)
6MWT distance (m) 403.7 (56.7)
Time since DMD diagnosis (MO) 55.2 (24.9)
Duration of corticosteroid use (MO) 36.8 (25.9)
Patient Id Mutation
1 ∆49–52
2 ∆45–52
3 ∆45–52
4 ∆45–52
5 ∆49–52
6 ∆48–52
7 ∆48–52
8 ∆45–52
9 ∆48–52
10 ∆50–52
11 ∆50–52
12 ∆49–52
13 ∆45–52
14 ∆45–52
15 ∆49–52
16 ∆52
17 ∆50–52
18 ∆45–52
19 ∆45–52
20 ∆48–52
21 ∆49–52
22 ∆50–52
23 ∆48–52
24 ∆52
25 ∆52
  1. 6MWT 6-minute walk test, BMI body mass index, DMD Duchenne muscular dystrophy
  2. Values are shown as mean (SD)
  3. ∆ deletion of exons